Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05047094
Title A Safety and Efficacy Study for Combinational Treatment of DaRT and Check Point Inhibitor for Recurrent Unresectable or mHNSCC
Recruitment Recruiting
Gender both
Phase
Variant Requirements No
Sponsors Alpha Tau Medical LTD.
Indications
Therapies
Age Groups: senior | adult
Covered Countries ISR

Facility Status City State Zip Country Details
Sharett institute, Hadassah University Hospital - Ein-Kerem RECRUITING Jerusalem 91120 Israel Details
Sheba Medical Center RECRUITING Ramat Gan Israel Details
Tel-Aviv Medical Center NOT_YET_RECRUITING Tel Aviv Israel Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field